Likewise, when the incretin effect on total insulin secretion was plotted against the OGTT/IIGI ratio of mean hormone concentrations, the individual dose trajectories for the patients with T2D ran consistently below those of the NGT individuals (Figure 7). The gene discussed is INS; the disease is type 2 diabetes mellitus.